Match Document Document Title
10620218 Method for predicting recurrence and progression of urothelial cancer patient after treatment  
The present disclosure relates to a method for predicting a recurrence and a progression of an urothelial cancer patient after a treatment including steps as follows. A urine sample is obtained...
10620209 Specific biomarker set for non-invasive diagnosis of liver cancer  
Cells within liver tumour mass comprise a unique set of proteins/tumour antigens when compared to the normal liver tissues epithelial cells juxtaposed to the tumour. The presence of tumour...
10620208 Classifying a cancer disease using CAIX expression  
The present invention relates to a carbonic anhydrase IX targeting compound for the use in the treatment of cancer, wherein the use comprises quantifying CAIX expression as well as the...
10620207 Method of identifying treatment responsive non-small cell lung cancer using anaplastic lymphoma kinase (ALK) as a marker  
Disclosed herein are methods for identifying a subject as having NSCLC that is predicted or is likely to respond to treatment with an ALK inhibitor, for example crizotinib. The methods include...
10620206 Biomarker for detecting cancer  
Methods for detecting colorectal cancer in a subject by detection of a galactose-containing 40 kDa molecule in a serum sample from the subject. Methods for quantifying the amount of a...
10620186 Method for capturing cancer cells  
The present invention provides a method for capturing cancer cells which can capture many types of cancer cells, including cancer cells not expressing EpCAM. The present invention relates to a...
10620150 Electromechanical approach for cancer detection  
A single-cell-based electromechanical method for cancerous state detection including the steps of preparing a suspension of individually suspended biological cells, extracting a single cell from...
10619215 Prediction of likelihood of cancer recurrence  
The present invention provides gene sets the expression of which is important in the diagnosis and/or prognosis of cancer, in particular of breast cancer.
10619214 Detecting genetic aberrations associated with cancer using genomic sequencing  
Methods, systems, and apparatus determine whether a first chromosomal region exhibits a deletion or an amplification associated with cancer in a sample from a subject (e.g., where the sample...
10619213 Prostate cancer detection kit or device, and detection method  
An object of the present invention is to provide a kit or a device for the detection of prostate cancer and a method for detecting prostate cancer. The present invention provides a kit or a device...
10619212 Esophageal cancer detection kit or device, and detection method  
It is intended to provide a kit or a device for the detection of esophageal cancer and a method for detecting esophageal cancer. The present invention provides a kit or a device for the detection...
10619157 Cancer treatment  
In certain embodiments, methods, compounds, and compositions for treating B-cell lymphoma or hepatocellular carcinoma by inhibiting expression of STAT3 mRNA or protein in an animal are provided...
10618970 Method of treating cancer with IL-10 and antibodies that induce ADCC  
Methods of treating subjects having a proliferative disease, disorder, or condition, including cancer, via the administration of an IL-10 agent, including pegylated IL-10, in combination with an...
10618967 Anti-CSF1R antibody and anti PD-1 antibody combination therapy for cancer  
Methods of treating cancer with antibodies that bind colony stimulating factor 1 receptor (CSF1R) in combination with PD-1/PD-L1 inhibitors are provided.
10618948 Peptides and combination of peptides for use in immunotherapy and methods for generating scaffolds for the use against pancreatic cancer and other cancers  
The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The...
10618944 Tumor suppressor SALL1 as a therapeutic agent for treating cancer  
The present disclosure relates to the SALL1 tumor suppressor. Methods of employing SALL1 to treat cancer, as well as the underlying mechanism by which this occurs, also are described.
10618930 Compounds for the treatment of cancer  
Provided herein are compounds useful for the treatment of cancer.
10618905 Pyrimidine-based compounds for the treatment of cancer  
This invention is in the area of pyrimidine-based compounds for the treatment of disorders involving abnormal cellular proliferation, including but not limited to tumors and cancers.
10617758 Anti-cancer vaccine combination  
The invention relates to an anti-cancer vaccine combination. Particularly, the invention relates to a pharmaceutical combination comprising a PD-L1/PD-1 expression inhibitor in combination with a...
10617749 Composition of matter and methods for alteration of dendritic cell metabolism to augment cancer vaccine efficacy  
This disclosure provides compositions of matter and methods for alteration of dendritic cell metabolism to augment cancer vaccine efficacy. The compositions and methods can involve regulation of...
10617743 Method to improve safety and efficacy of anti-cancer therapy  
The invention relates to the use of a deoxyribonuclease (DNase) enzyme for prevention or amelioration of toxicity associated with various cytostatic and/or cytotoxic chemotherapeutic compounds and...
10617717 Methods of treating lung cancer by predicting responders to cisplatin-pemetrexed combination therapy  
Methods are provided for identifying whether a lung tumor will be responsive to treatment with the combination of the therapeutic agents cisplatin and pemetrexed. Specified ERCC1, TS, p16, and FRα...
10617706 Compounds for cancer chemotherapeutic sensitization  
The invention provides a compound of formula (I), (II) or (III): wherein R1, R2, R3, R4 and R5 have any of the values described in the specification, as well as compositions comprising a compound...
10617685 Nonsteroidal and steroidal compounds with potent androgen receptor down-regulation and anti prostate cancer activity  
Nonsteroid and steroid compounds that cause down-regulation of the androgen receptor (AR), both full length and splice variant, induce apoptosis and inhibit proliferation of inhibiting...
D880698 Cover for cancer cell observation camera  
10614920 System and method for computing survivorship risk associated with delaying therapy in breast cancer  
An estimate is made of a time since a given presenting cancer would have first been detectable using a known diagnostic technique, and an estimate is also made of initial characteristics of the...
10613091 Methods of developing a prognosis for pancreatic cancer and predicting responsiveness to cancer therapeutics  
Methods of predicting responsiveness of a cancer in a subject to a cancer therapy including a VEGF targeting agent are provided herein. The methods include detecting the expression level of at...
10613090 Methods of detecting cancer  
The present disclosure is directed toward methods and kits for detecting cancer, and in particular breast cancer, in a subject by measuring the levels of at least one of the identified markers, as...
10613015 Methods for classification and sorting of cancer cells  
A particle analysis system includes an inlet; an inertial focusing microchannel disposed in a substrate and having a downstream expanding region at a distal end, where the inlet is connected to a...
10612026 Pharmaceutical composition for treating cancer comprising microrna as active ingredient  
The present invention relates to a pharmaceutical composition for treatment of cancer, which comprises, as an active ingredient, one or more miRNAs selected from the group consisting of miR-3670,...
10611836 Methods of treating cancer using PD-1 axis binding antagonists and tigit inhibitors  
The present invention describes combination treatment comprising a PD-1 axis binding antagonist and an agent that decreases or inhibits TIGIT expression and/or activity and methods for use...
10611835 Pharmaceutical composition for treatment and prevention of cancer  
An antibody or a fragment thereof having immunoreactivity to a polypeptide comprising not less than 7 continuous amino acids in the CD179b protein, which was identified as a cancer antigen protein...
10611814 Universal chimeric antigen expressing immune cells for targeting of diverse multiple antigens and method of manufacturing the same and use of the same for treatment of cancer, infections and autoimmune disorders  
The present invention relates to immune cell-based anti-cancer therapeutics and methods of using the therapeutics in the treatment of cancer.
10611797 Peptide having anticancer activity, and pharmaceutical composition and dietary supplement composition for preventing and treating cancer, both of which contain same as active ingredient  
A peptide binding to transcription factor CP2c, having an activity of preventing and treating cancer and represented by SEQ ID NO: 1: Asn-Tyr-Pro-Gln-Arg-Pro, and a pharmaceutical composition and...
10611766 Pyrazolopyrimidine derivatives as BTK inhibitors for the treatment of cancer  
This invention relates to novel compounds. The compounds of the invention are tyrosine kinase inhibitors. Specifically, the compounds of the invention are useful as inhibitors of Bruton's tyrosine...
10611761 Selective EP4 receptor antagonistic substance for treatment of cancer  
This invention provides a medicament for the treatment of cancer, which cause a reduction of cancer. This invention relates to use of a compound which has inhibitory activities against...
10610578 Checkpoint inhibitor and a whole cell mycobacterium for use in cancer therapy  
An immunomodulator for use in the treatment, reduction, inhibition or control of a neoplastic disease in a patient intended to undergo checkpoint inhibition therapy, simultaneously, separately or...
10610577 Checkpoint inhibitor and a whole cell Mycobacterium for use in cancer therapy  
An immunomodulator is for use in the treatment, reduction, inhibition or control of a neoplastic disease in a patient intended to undergo checkpoint inhibition therapy, simultaneously, separately...
10610514 Composition comprising compound inhibiting interactions of MBD2 and P66α for anti-metastasis and prevention and treatment of cancer disease  
The present invention relates to a composition including an inhibitor against the function of an Mi-2/NuRD chromatin remodeling complex for inhibiting metastasis and preventing and treating cancer...
10610484 Methods of using albumin-CD20 paclitaxel nanoparticle complex compositions for treating cancer  
Described herein are compositions of antibodies and carrier proteins and methods of making and using the same, in particular, as a cancer therapeutic. Also described are lyophilized compositions...
D879962 Cover for cancer cell observation camera  
10605812 Method for predicting the risk of getting cancer or diagnosing cancer in a subject  
A method for predicting the risk of getting cancer in a subject that does not suffer from cancer or alternatively diagnosing cancer in a subject, where the method includes determining the level of...
10605811 Predictive biomarkers for ovarian cancer  
Methods are provided for predicting the presence, subtype and stage of ovarian cancer, as well as for assessing the therapeutic efficacy of a cancer treatment and determining whether a subject...
10604812 Materials and methods for assessing progression of prostate cancer  
Methods of distinguishing and identifying a patient with aggressive/indolent, prostatic adenocarcinoma comprising contacting a sample from the patient with a set of detectably labeled probes under...
10604810 Colorectal cancer detection kit or device, and detection method  
It is intended to provide a kit or a device for the detection of colorectal cancer and a method for detecting colorectal cancer. The present invention provides a kit or a device for the detection...
10604809 Methods and kits for the diagnosis and treatment of pancreatic cancer  
The present disclosure relates to the identification of genes and gene combinations that are correlated with patients having or being predisposed to developing pancreatic ductal adenocarcinoma...
10604575 Cancer immunotherapy by disrupting PD-1/PD-L1 signaling  
The disclosure provides a method for immunotherapy of a subject afflicted with cancer, comprises administering to the subject a composition comprising a therapeutically effective amount of an...
10604568 Diagnosis and therapy of cancer involving cancer stem cells  
The present invention provides methods for diagnosis or treatment of cancer diseases involving cancer stem cells comprising targeting CLDN6. In particular, the present invention provides a method...
10604565 Monoclonal antibodies to growth and differentiation factor 15 (GDF-15), and uses thereof for treating cancer cachexia and cancer  
The present invention relates to monoclonal anti-human-GDF-15 antibodies. The antibodies include chimeric antibodies and humanized antibodies. The invention also relates to monoclonal...
10604542 Cyclic dinucleotides for treating conditions associated with sting activity such as cancer  
This disclosure features dinucleotide compounds that modulate Stimulator of Interferon Genes (STING) activity, for use for example in the treatment of cancer. This disclosure also features...